论文部分内容阅读
目的观察奥硝唑治疗滴虫性阴道炎的临床疗效和安全性。方法将106例滴虫性阴道炎患者随机分为奥硝唑组和替硝唑组各53例。分别采用奥硝唑和替硝唑口服治疗。结果奥硝唑组和替硝唑组的总有效率分别为100%和86.8%,两组比较差异有显著性(P<0.05);奥硝唑组和替硝唑组发生不良反应的比率分别为7.5%(4/53)和24.5%(13/53),两组比较差异也有显著性(P<0.05)。结论奥硝唑治疗滴虫性阴道炎安全、有效,不良反应少,可作为该病的首选药物。
Objective To observe the clinical efficacy and safety of ornidazole in the treatment of trichomonas vaginitis. Methods 106 cases of trichomonas vaginitis were randomly divided into ornidazole group and tinidazole group of 53 cases. Ornidazole and tinidazole were used orally. Results The total effective rates of the ornidazole group and the tinidazole group were 100% and 86.8%, respectively, with significant differences between the two groups (P <0.05). The rates of adverse reactions in the ornidazole group and the tinidazole group were respectively Were 7.5% (4/53) and 24.5% (13/53) respectively. There was also significant difference between the two groups (P <0.05). Conclusion Ornidazole treatment of trichomonas vaginitis safe, effective, fewer adverse reactions, can be used as the drug of choice.